uniQure N.V (NASDAQ:QURE)’s traded shares stood at 1.3 million during the last session, with the company’s beta value hitting 0.42. At the close of trading, the stock’s price was $13.99, to imply an increase of 5.74% or $0.76 in intraday trading. The QURE share’s 52-week high remains $19.18, putting it -37.1% down since that peak but still an impressive 73.34% since price per share fell to its 52-week low of $3.73. The company has a valuation of $747.59M, with an average of 1.55 million shares in intraday trading volume over the past 10 days and average of 2.17 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for uniQure N.V (QURE), translating to a mean rating of 1.33. Of 7 analyst(s) looking at the stock, 0 analyst(s) give QURE a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.51.
uniQure N.V (NASDAQ:QURE) trade information
After registering a 5.74% upside in the last session, uniQure N.V (QURE) has traded red over the past five days. The 5-day price performance for the stock is -20.69%, and -7.10% over 30 days. With these gigs, the year-to-date price performance is -20.78%. Short interest in uniQure N.V (NASDAQ:QURE) saw shorts transact 3.39 million shares and set a 0.72 days time to cover.
The extremes give us $24 and $24 for target low and target high price respectively. As such, QURE has been trading -71.55% off suggested target high and -71.55% from its likely low.
uniQure N.V (QURE) estimates and forecasts
Looking at statistics comparing uniQure N.V share performance against respective industry, we note that the company has outperformed competitors. uniQure N.V (QURE) shares are 51.90% up over the last 6 months, with its year-to-date growth rate higher than industry average at 42.19% against 16.70%. The rating firms project that company’s revenue will grow 157.30% compared to the previous financial year.
Revenue forecast for the current quarter as set by 11 analysts is 18.46M. Meanwhile, for the current quarter, a total of 8 analyst(s) estimate revenue growth to 6.37M.Earnings reports from the last fiscal year show that sales brought in 6.16M and 7.87M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 199.48% before dropping -19.06% in the following quarter.
QURE Dividends
uniQure N.V has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
uniQure N.V (NASDAQ:QURE)’s Major holders
uniQure N.V insiders hold 8.48% of total outstanding shares, with institutional holders owning 81.46% of the shares at 89.01% float percentage. In total, 81.46% institutions holds shares in the company, led by VESTAL POINT CAPITAL, LP. As of 2024-06-30, the company held over 4.75 million shares (or 9.8172% of shares), all amounting to roughly $21.28 million.
The next major institution holding the largest number of shares is NANTAHALA CAPITAL MANAGEMENT, LLC with 2.65 million shares, or about 5.4779% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $11.87 million.
We also have abrdn Healthcare Investors and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the uniQure N.V (QURE) shares. Going by data provided on Sep 30, 2024 , abrdn Healthcare Investors holds roughly 1.04 shares. This is just over 2.13% of the total shares, with a market valuation of $14.54 million. Data from the same date shows that the other fund manager holds a little less at 736.63, or 1.51% of the shares, all valued at about 10.31 million.
